PETERS KEVIN G. 4
4 · Aerpio Pharmaceuticals, Inc. · Filed Apr 25, 2018
Insider Transaction Report
Form 4
PETERS KEVIN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-04-23+100,000→ 100,000 totalExercise: $3.59Exp: 2028-04-23→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.